Whole-exome-sequencing (WES) is increasingly used to screen for causal mutations and such studies have identified pathogenic variants in a proportion of VEO-IBD patients, in genes such as IL10, IL10RA, IL10RB, XIAP, TTC7A, and TTC3712–18. Here, XIAP is linked to inflammatory bowel disease.